[go: up one dir, main page]

NO20014091L - Transplantasjon av hematopoietiske celler - Google Patents

Transplantasjon av hematopoietiske celler

Info

Publication number
NO20014091L
NO20014091L NO20014091A NO20014091A NO20014091L NO 20014091 L NO20014091 L NO 20014091L NO 20014091 A NO20014091 A NO 20014091A NO 20014091 A NO20014091 A NO 20014091A NO 20014091 L NO20014091 L NO 20014091L
Authority
NO
Norway
Prior art keywords
transplantation
hematopoietic cells
disease
treatment
stem cells
Prior art date
Application number
NO20014091A
Other languages
English (en)
Other versions
NO20014091D0 (no
Inventor
Jack Price
Original Assignee
Reneuron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Ltd filed Critical Reneuron Ltd
Publication of NO20014091D0 publication Critical patent/NO20014091D0/no
Publication of NO20014091L publication Critical patent/NO20014091L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Psychology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Transplantasjon av hematopoietiske stamceller for behandling av en skadet hjerne. Intracerebral transplantasjon av hematopoietiske stamceller kan reparere funksjon og kan være egnet for behandling av Alzheimers sykdom, Parkinsons sykdom og Creuzfeld-Jacobs sykdom.
NO20014091A 1999-02-24 2001-08-23 Transplantasjon av hematopoietiske celler NO20014091L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904281.4A GB9904281D0 (en) 1999-02-24 1999-02-24 Transplantation
PCT/GB2000/000636 WO2000050568A2 (en) 1999-02-24 2000-02-23 Transplantation of haematopoietic cells

Publications (2)

Publication Number Publication Date
NO20014091D0 NO20014091D0 (no) 2001-08-23
NO20014091L true NO20014091L (no) 2001-08-23

Family

ID=10848438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014091A NO20014091L (no) 1999-02-24 2001-08-23 Transplantasjon av hematopoietiske celler

Country Status (20)

Country Link
EP (1) EP1161521B1 (no)
JP (1) JP4716575B2 (no)
KR (1) KR20020000216A (no)
CN (1) CN1636053A (no)
AT (1) ATE237680T1 (no)
AU (1) AU762763B2 (no)
CA (1) CA2361401A1 (no)
CZ (1) CZ20012651A3 (no)
DE (1) DE60002185T2 (no)
DK (1) DK1161521T3 (no)
ES (1) ES2193938T3 (no)
GB (1) GB9904281D0 (no)
HK (1) HK1041284B (no)
HU (1) HUP0105168A3 (no)
NO (1) NO20014091L (no)
PL (1) PL350297A1 (no)
PT (1) PT1161521E (no)
RU (1) RU2216336C2 (no)
SK (1) SK11232001A3 (no)
WO (1) WO2000050568A2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518606D0 (en) 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
CA2373808C (en) * 1999-05-14 2011-04-19 Henry Ford Health System Bone marrow transplantation for treatment of central nervous system damage
US8017112B2 (en) 1999-05-14 2011-09-13 Henry Ford Health System Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
JP4623967B2 (ja) * 2002-01-14 2011-02-02 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 幹細胞の移動および増殖を促進するための修飾されたピリミジン化合物の使用
AU2003280824A1 (en) * 2002-11-15 2004-06-15 Fumihiko Ishikawa Method of organ regeneration
ES2294650T3 (es) 2004-09-30 2008-04-01 Reneuron Limited Linea celular.
RU2283119C1 (ru) * 2005-03-29 2006-09-10 Андрей Степанович БРЮХОВЕЦКИЙ Препарат аутологичных гемопоэтических стволовых клеток, способ его получения, криоконсервации и использования для лечения травматической болезни центральной нервной системы
US7569545B2 (en) * 2005-05-20 2009-08-04 Academia Sinica Methods of increasing neurotrophic factor expression
CN101495623B (zh) 2006-03-24 2013-09-11 儿童医疗中心有限公司 调节造血干细胞生长的方法
US9402852B2 (en) 2006-10-20 2016-08-02 Children's Medical Center Corporation Method to enhance tissue regeneration
JP5555922B2 (ja) 2008-09-16 2014-07-23 ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション，インコーポレイテッド 脱毛を治療する、又は、脱毛の発症を遅らせるための組成物
WO2010096264A2 (en) 2009-02-03 2010-08-26 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
WO2010091052A2 (en) 2009-02-03 2010-08-12 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
GB0902034D0 (en) 2009-02-06 2009-03-11 Reneuron Ltd Method
DK2699247T3 (en) * 2011-04-20 2018-06-14 Univ California PROCEDURE FOR COMBINED CONDITIONING AND CHEMOS SELECTION IN A SIMPLE CYCLE
EP2785350B1 (en) 2011-12-02 2018-05-02 Fate Therapeutics, Inc. Improved methods of treating ischemia
ES2836976T3 (es) 2011-12-02 2021-06-28 Fate Therapeutics Inc Composición mejorada de células madre
WO2014150602A1 (en) 2013-03-15 2014-09-25 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
RU2647429C1 (ru) * 2017-02-06 2018-03-15 Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) Биомедицинский клеточный препарат
RU2720002C1 (ru) * 2018-12-28 2020-04-23 Андрей Степанович БРЮХОВЕЦКИЙ Биомедицинский клеточный продукт для лечения нервных болезней и психических расстройств, способ его получения и его применение
CN114934072B (zh) * 2022-05-18 2023-10-20 华中科技大学同济医学院附属协和医院 一种人心脏瓣膜间质细胞系的永生化构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
EP0631618A4 (en) * 1992-03-04 1995-09-27 Systemix Inc CULTIVATION OF HEMOPOETIC STEM CELLS AND THEIR GENETOLOGICAL PRODUCTION.
IL122752A (en) * 1995-06-27 2001-07-24 Boehringer Ingelheim Kg Stable preparations for creating propellant-free sprays
GB9518606D0 (en) * 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
EP0934403A4 (en) * 1996-08-19 2001-03-14 Univ Massachusetts ROWS OF EMBRYONIC OR STRAIN-LIKE CELLS PRODUCED BY CROSS NUCLEAR TRANSPLANTATION OF SPECIES

Also Published As

Publication number Publication date
SK11232001A3 (sk) 2002-01-07
CN1636053A (zh) 2005-07-06
JP2002537406A (ja) 2002-11-05
AU2682100A (en) 2000-09-14
ATE237680T1 (de) 2003-05-15
KR20020000216A (ko) 2002-01-05
GB9904281D0 (en) 1999-04-21
DE60002185D1 (de) 2003-05-22
HUP0105168A3 (en) 2003-12-29
DK1161521T3 (da) 2003-06-16
EP1161521A2 (en) 2001-12-12
PL350297A1 (en) 2002-12-02
JP4716575B2 (ja) 2011-07-06
HUP0105168A2 (hu) 2002-05-29
NO20014091D0 (no) 2001-08-23
WO2000050568A3 (en) 2000-12-07
DE60002185T2 (de) 2003-12-18
HK1041284A1 (en) 2002-07-05
CA2361401A1 (en) 2000-08-31
WO2000050568A2 (en) 2000-08-31
CZ20012651A3 (cs) 2002-01-16
RU2216336C2 (ru) 2003-11-20
HK1041284B (zh) 2003-10-03
ES2193938T3 (es) 2003-11-16
PT1161521E (pt) 2003-08-29
AU762763B2 (en) 2003-07-03
EP1161521B1 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
NO20014091L (no) Transplantasjon av hematopoietiske celler
NO20004803L (no) Smilagening og anzurogenin for behandling av Alzheimers sykdom
DK1224297T3 (da) Alzheimers sygdom -sekretase, APP-substrater derfor og anvendelser deraf
AU2002343557A1 (en) Substituted aryl 1,4-pyrazine derivatives
MY130489A (en) Substituted aryl 1, 4-pyrazine derivatives
CA2336833A1 (en) Remedy with antidepressant effects
MXPA02004881A (es) Genes de rasgos o cualidades de las semillas.
EP1767197A3 (en) Treatment of Alzheimer's disease with inhibitors of cell cycle re-entry and progression
DK0484281T4 (da) Cyclosporiner
EG23427A (en) Cultivated agarwood.
GB0400167D0 (en) Dopaminergic neurons and proliferation-competent orecursor cells for treating parkinson's disease
FR2808437B1 (fr) Prothese de reparation herniaire
TW367365B (en) An improved method for obtaining plant somatic embryos about the somatic embryo suspension cultures and pro-embryogenic mass suspension cultures
TW200503717A (en) Substituted 1,4-pyrazine derivatives
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
HK1080408B (zh) 溴莫尼定在治療痴呆和帕金森病中的用途
DE59707667D1 (de) Prothetische Gelenkpfanne
DE69729807D1 (de) Herstellung von zweiwegformgedächtnisteilen
EP1566444A3 (en) Yield-related genes
IL142240A0 (en) Organic medium for plant cultivation and biological capsule based on the organic medium
GR1004103B (el) Συγκροτημα ξηραντηριου μετα δεματοποιησης χορτονομων (τριφυλιου και λοιπων χορτων)
IT1307785B1 (it) Impianto e kit per la fabbricazione di accoppiati tessili.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application